Yusuke Terada

593 total citations · 1 hit paper
16 papers, 417 citations indexed

About

Yusuke Terada is a scholar working on Pathology and Forensic Medicine, Immunology and Oncology. According to data from OpenAlex, Yusuke Terada has authored 16 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 5 papers in Immunology and 4 papers in Oncology. Recurrent topics in Yusuke Terada's work include Multiple Sclerosis Research Studies (5 papers), Drug Transport and Resistance Mechanisms (4 papers) and Immunotherapy and Immune Responses (4 papers). Yusuke Terada is often cited by papers focused on Multiple Sclerosis Research Studies (5 papers), Drug Transport and Resistance Mechanisms (4 papers) and Immunotherapy and Immune Responses (4 papers). Yusuke Terada collaborates with scholars based in Japan, United States and Canada. Yusuke Terada's co-authors include Benjamin Greenberg, Takashi Yamamura, Yuichi Kawata, Brian G. Weinshenker, Athos Gianella-Borradori, Anthony Traboulsee, Jeffrey L. Bennett, Edward Fox, Svitlana Shkrobot and Pádraig Wright and has published in prestigious journals such as Neurology, The Lancet Neurology and International Journal of Pharmaceutics.

In The Last Decade

Yusuke Terada

14 papers receiving 410 citations

Hit Papers

Safety and efficacy of satralizumab monotherapy in neurom... 2020 2026 2022 2024 2020 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial
    2020 317 citations Anthony Traboulsee, Benjamin Greenberg et al. The Lancet Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yusuke Terada Japan 7 277 241 73 71 47 16 417
Simona Toscano Italy 11 233 0.8× 148 0.6× 61 0.8× 60 0.8× 95 2.0× 24 422
Kimberly M. Winges United States 9 176 0.6× 74 0.3× 50 0.7× 70 1.0× 29 0.6× 14 353
Robert Herndon United States 11 433 1.6× 199 0.8× 142 1.9× 91 1.3× 166 3.5× 16 548
J Scott Sloka Canada 8 228 0.8× 52 0.2× 71 1.0× 102 1.4× 64 1.4× 11 383
Shaul Kadosh United States 6 333 1.2× 191 0.8× 111 1.5× 65 0.9× 70 1.5× 11 430
Christopher LaGanke United States 9 193 0.7× 80 0.3× 65 0.9× 66 0.9× 72 1.5× 28 287
René M. Gieß Germany 11 224 0.8× 73 0.3× 69 0.9× 74 1.0× 71 1.5× 16 333
Cristina Valencia-Sánchez United States 12 116 0.4× 239 1.0× 40 0.5× 19 0.3× 72 1.5× 30 379
Maria Roberta Bongioanni Italy 8 190 0.7× 93 0.4× 97 1.3× 61 0.9× 95 2.0× 11 280
S. Galgani Italy 12 226 0.8× 120 0.5× 97 1.3× 213 3.0× 88 1.9× 15 533

Countries citing papers authored by Yusuke Terada

Since Specialization
Citations

This map shows the geographic impact of Yusuke Terada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yusuke Terada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yusuke Terada more than expected).

Fields of papers citing papers by Yusuke Terada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yusuke Terada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yusuke Terada. The network helps show where Yusuke Terada may publish in the future.

Co-authorship network of co-authors of Yusuke Terada

This figure shows the co-authorship network connecting the top 25 collaborators of Yusuke Terada. A scholar is included among the top collaborators of Yusuke Terada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yusuke Terada. Yusuke Terada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Terada, Yusuke, Kosuke Tanaka, Masatoshi Nozaki, et al.. (2024). Furosemide for patent ductus arteriosus during cyclooxygenase inhibitor therapy: A systematic review. Pediatrics International. 66(1). e15822–e15822. 1 indexed citations
2.
Traboulsee, Anthony, Benjamin Greenberg, Jeffrey L. Bennett, et al.. (2020). Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial. The Lancet Neurology. 19(5). 402–412. 317 indexed citations breakdown →
3.
Bennett, Jeffrey L., Benjamin Greenberg, Anthony Traboulsee, et al.. (2020). Efficacy of Satralizumab As Monotherapy in Pre-Specified Subgroups of Sakurastar, a Double-Blind Placebo-Controlled Phase 3 Clinical Study in Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD). Multiple Sclerosis and Related Disorders. 37. 101576–101576. 1 indexed citations
4.
Hašková, Zdenka, Benjamin Frishberg, J. de Sèze, et al.. (2020). Efficacy and safety of satralizumab from two phase 3 trials in neuromyelitis optica spectrum disorder. 61(7). 3173–3173. 1 indexed citations
5.
Sèze, J. de, Brian G. Weinshenker, Yusuke Terada, et al.. (2020). Efficacy and Safety of Satralizumab for Relapse Prevention in Neuromyelitis Optica Spectrum Disorder: A Pooled Analysis from Two Phase 3 Clinical Trials. Multiple Sclerosis and Related Disorders. 37. 101592–101592. 2 indexed citations
6.
7.
Terada, Yusuke, et al.. (2018). Early detection of virus infection in live human cells using Raman spectroscopy. Journal of Biomedical Optics. 23(9). 1–1. 18 indexed citations
8.
Terada, Yusuke, et al.. (2017). AN ESTIMATION METHOD OF PORE WATER PRESSURE USING FIELD MONITORING DATA AND TANK MODEL REGARDING SURFACE FAILURE. Journal of Japan Society of Civil Engineers Ser C (Geosphere Engineering). 73(2). 141–156. 1 indexed citations
9.
10.
Suzuki, Shunji, et al.. (2015). Trisomy 13 and Massive Fetomaternal Hemorrhage. Journal of Clinical Medicine Research. 7(7). 564–565. 2 indexed citations
11.
Terada, Yusuke, Jiro Ogura, Takashi Tsujimoto, et al.. (2014). Intestinal P-glycoprotein Expression is Multimodally Regulated by Intestinal Ischemia-Reperfusion. Journal of Pharmacy & Pharmaceutical Sciences. 17(2). 266–266. 23 indexed citations
12.
Tsujimoto, Takashi, Jiro Ogura, Takahiro Koizumi, et al.. (2013). Effect of oxidative stress on expression and function of human and rat organic anion transporting polypeptides in the liver. International Journal of Pharmaceutics. 458(2). 262–271. 9 indexed citations
13.
14.
Maruyama, Hajime, Jiro Ogura, Yusuke Terada, et al.. (2013). Intestinal Ischemia-Reperfusion Suppresses Biliary Excretion of Hepatic Organic Anion Transporting Polypeptides Substrate. Journal of Pharmacy & Pharmaceutical Sciences. 16(5). 722–722. 2 indexed citations
15.
Ogura, Jiro, Yusuke Terada, Takashi Tsujimoto, et al.. (2012). Intestinal Ischemia-Reperfusion Increases Efflux for Uric Acid Via Paracellular Route in the Intestine, but Decreases that Via Transcellular Route Mediated by BCRP. Journal of Pharmacy & Pharmaceutical Sciences. 15(2). 295–295. 13 indexed citations
16.
Ogura, Jiro, Yusuke Terada, Takashi Tsujimoto, et al.. (2012). The Decrease in Farnesoid X Receptor, Pregnane X Receptor and Constitutive Androstane Receptor in the Liver after Intestinal Ischemia-Reperfusion. Journal of Pharmacy & Pharmaceutical Sciences. 15(5). 616–616. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simona Toscano Breakdown of academic impact, for papers by Kimberly M. Winges Breakdown of academic impact, for papers by Robert Herndon Breakdown of academic impact, for papers by J Scott Sloka Breakdown of academic impact, for papers by Shaul Kadosh Breakdown of academic impact, for papers by Christopher LaGanke Breakdown of academic impact, for papers by René M. Gieß Breakdown of academic impact, for papers by Cristina Valencia-Sánchez Breakdown of academic impact, for papers by Maria Roberta Bongioanni Breakdown of academic impact, for papers by S. Galgani
Rankless by CCL
2026